Kolexia
Brasseur Mathilde Gastro-entérologie
Brasseur Mathilde
Gastro-entérologie
Hôpital Robert-Debré Reims
Reims, France
58 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de l'appareil digestif Tumeurs gastro-intestinales Sarcopénie Malnutrition Tumeurs stromales gastro-intestinales Tumeurs du pancréas Faiblesse musculaire Adénocarcinome Hypersensibilité médicamenteuse

Collaborateurs

Voir plus
Bouche Olivier
Bouche Olivier
Hôpital Robert-Debré Reims, Reims, France
Botsen Damien
Botsen Damien
Institut Godinot, Reims, France
Volet Julien
Volet Julien
Polyclinique Reims - Bezannes, Bezannes, France
Perrier Marine
Perrier Marine
Hôpital Robert-Debré Reims, Reims, France

Industries

Voir plus
Amgen
14 collaboration(s)
Dernière en 2023
Servier
8 collaboration(s)
Dernière en 2023
MSD
3 collaboration(s)
Dernière en 2023
Sanofi
3 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
Efficiency of Imatinib Treatment After 10 Years of Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (Gist-Ten): Randomized, Multicentre, Phase II Study Evaluating the Interest of Imatinib Treatment Maintenance or Interruption After at Least 10 Years of Treatment in Patients With Locally Advanced/Metastatic Gastrointestinal Stromal Tumors (GISTs)
Essai Clinique (Centre Léon-Bérard)   31 août 2023
Genetic counselling referral practices for patients with pancreatic adenocarcinoma: A French retrospective multicentre observational cohort study (CAPANCOGEN).
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]   19 juin 2023
LENVAGIST: A Multicentre, Comparative, Placebo-controlled, Double-blinded, Phase II Study of the Efficacy of Lenvatinib in Patients With Locally Advanced or Metastatic GIST After Failure of Imatinib and Sunitinib
Essai Clinique (Centre Léon-Bérard)   28 mars 2023
Incidence and associated factors of cetuximab-induced hypersensitivity infusion reactions in 1392 cancer patients treated in four French areas: a possible association with Lyme disease?
BMC cancer   25 novembre 2022
Neoadjuvant chemotherapy for borderline resectable and upfront resectable pancreatic cancer increasing overall survival and disease-free survival?
Frontiers in oncology   25 octobre 2022
Feasibility and Impact of Adapted Physical Activity (APA) in Cancer Outpatients Beginning Medical Anti-Tumoral Treatment: The UMA-CHAPA Study.
Cancers   14 avril 2022
Dynapenia in digestive cancer outpatients: association with markers of functional and nutritional status (the FIGHTDIGO study).
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer   12 juillet 2021
PET/CT of Duodenal Gangliocytic Paraganglioma.
Clinical nuclear medicine   27 août 2020
Time intervals to diagnosis and chemotherapy do not influence survival outcome in patients with advanced pancreatic adenocarcinoma.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   30 avril 2020
Multidisciplinary approach for Borderline pancreatic adenocarcinoma of the head of the pancreas
HPB : the official journal of the International Hepato Pancreato Biliary Association   01 janvier 2020